Quantcast

Latest Direct thrombin inhibitors Stories

2014-07-23 16:26:55

British Medical Journal publishes biased article regarding PRADAXA RIDGEFIELD, Conn., July 23, 2014 /PRNewswire/ -- Boehringer Ingelheim (BI) wants to set the record straight following misleading statements that the British Medical Journal (BMJ) published today regarding Pradaxa® (dabigatran etexilate mesylate). We are concerned that this publication may alarm patients and prompt them to stop taking PRADAXA, thereby increasing their risk of stroke. To be clear, many of the allegations made...

2014-06-10 12:29:47

Additional Novel Oral Anticoagulants are Expected to Gain Approval in China for AF and VTE in the Next Three to Four Years, According to Findings from Decision Resources Group BURLINGTON, Mass., June 10, 2014 /PRNewswire/ -- Decision Resources Group finds that the high cost of therapy remains a significant barrier for uptake of novel oral anticoagulants (NOACs) in the Chinese market. Warfarin, the mainstay of anticoagulation treatment, is listed in the national essential drugs list and is...

2014-03-23 23:01:59

Federal Judge Overseeing More than 2,300 Pradaxa Lawsuits Schedules Four Bellwether Trials, First of Which Will Begin in September 2014. Columbus, OH (PRWEB) March 23, 2014 The federal judge overseeing thousands of Pradaxa lawsuits in the U.S. District Court, Southern District of Illinois, has established new dates for the litigation’s first bellwether trials, Wright & Schulte LLC reports. According to a Pretrial Order issued on March 5, 2014, by U.S. District Judge David Herndon,...

2014-01-29 23:28:36

As Pradaxa Bleeding Lawsuits Mount, FDA Announces Plan for Large Scale Assessment Comparing Pradaxa Bleeding Rates to Warfarin. Columbus, OH (PRWEB) January 29, 2014 The Pradaxa lawyers at Wright & Schulte LLC were pleased with news that the U.S. Food & Drug Administration (FDA) has planned a large scale-assessment comparing Pradaxa bleeding rates to those associated with warfarin. The announcement of the study comes as thousands of Pradaxa lawsuits that allege use of the drug...

2013-12-02 23:01:23

Pradaxa Lawsuits Pending in Federal Litigation Allege the Maker of the Blood Thinner Failed to Provide Adequate Warnings Regarding Pradaxa Bleeding Side Effects, Lack of Antidote to Reverse Hemorrhaging from The Drug. Colubus, OH (PRWEB) December 02, 2013 The products liability litigation surrounding Pradaxa continues to grow, as Wright & Schulte LLC notes that the number of Pradaxa lawsuits pending in a federal multidistrict litigation underway in U.S. District Court, Southern...

2013-03-15 23:02:41

The Rottenstein Law Group, a Pradaxa law firm, acknowledges that the FDA has conducted extensive research into the topic, but the firm is still actively monitoring reports of side effects and filing lawsuits on behalf of clients who believe that Pradaxa injured them. (PRWEB) March 15, 2013 Although there have been numerous Pradaxa lawsuits because of the anticoagulant drug´s alleged excessive bleeding side effects, the U.S. Food and Drug Administration issued a report* this week...

2012-09-07 23:03:08

Parker Waichman LLP is alerting the public about a new review published in the Journal of the American Medical Association (JAMA) that highlights the risks of expedited approval for drugs like Pradaxa (dabigatran). Originally hailed as an innovative warfarin replacement, Pradaxa is part of a new generation of anticoagulants that has been associated with uncontrollable bleeding risks. New York, NY (PRWEB) September 06, 2012 Parker Waichman LLP, a national law firm dedicated to protecting the...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related